Literature DB >> 24787470

The prevalence of microvascular dysfunction, its role among men, and links with adverse outcomes: noninvasive imaging reveals the tip of the iceberg.

John W Petersen1, Carl J Pepine2.   

Abstract

Entities:  

Keywords:  Editorials; coronary artery disease

Mesh：

Year:  2014        PMID： 24787470      PMCID： PMC4124593          DOI： 10.1161/CIRCULATIONAHA.114.010263

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  19 in total

1.  Validation of a new noninvasive method (contrast-enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve: comparison with intracoronary Doppler flow wire.

Authors:  C Caiati; C Montaldo; N Zedda; R Montisci; M Ruscazio; G Lai; M Cadeddu; L Meloni; S Iliceto
Journal:  J Am Coll Cardiol       Date:  1999-10       Impact factor: 24.094

2.  Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study.

Authors:  S E Reis; R Holubkov; A J Conrad Smith; S F Kelsey; B L Sharaf; N Reichek; W J Rogers; C N Merz; G Sopko; C J Pepine
Journal:  Am Heart J       Date:  2001-05       Impact factor: 4.749

Review 3.  Estimation of coronary flow reserve using the Thrombolysis In Myocardial Infarction (TIMI) frame count method.

Authors:  A Manginas; P Gatzov; C Chasikidis; V Voudris; G Pavlides; D V Cokkinos
Journal:  Am J Cardiol       Date:  1999-06-01       Impact factor: 2.778

4.  "False-positive" myocardial perfusion scintigraphy findings in patients with angiographically normal coronary arteries: insights from intravascular sonography studies.

Authors:  E Verna; L Ceriani; L Giovanella; G Binaghi; S Garancini
Journal:  J Nucl Med       Date:  2000-12       Impact factor: 10.057

5.  Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia.

Authors:  K Yoshida; N Mullani; K L Gould
Journal:  J Nucl Med       Date:  1996-10       Impact factor: 10.057

6.  The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation.

Authors:  Leslee J Shaw; C Noel Bairey Merz; Carl J Pepine; Steven E Reis; Vera Bittner; Kevin E Kip; Sheryl F Kelsey; Marian Olson; B Delia Johnson; Sunil Mankad; Barry L Sharaf; William J Rogers; Gerald M Pohost; George Sopko
Journal:  Circulation       Date:  2006-08-21       Impact factor: 29.690

7.  Prognostic value of coronary vascular endothelial dysfunction.

Authors:  Julian P J Halcox; William H Schenke; Gloria Zalos; Rita Mincemoyer; Abhiram Prasad; Myron A Waclawiw; Khaled R A Nour; Arshed A Quyyumi
Journal:  Circulation       Date:  2002-08-06       Impact factor: 29.690

8.  Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Gregory O von Mering; Christopher B Arant; Timothy R Wessel; Susan P McGorray; C Noel Bairey Merz; Barry L Sharaf; Karen M Smith; Marian B Olson; B Delia Johnson; George Sopko; Eileen Handberg; Carl J Pepine; Richard A Kerensky
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

9.  TIMI frame count: a quantitative method of assessing coronary artery flow.

Authors:  C M Gibson; C P Cannon; W L Daley; J T Dodge; B Alexander; S J Marble; C H McCabe; L Raymond; T Fortin; W K Poole; E Braunwald
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

Review 10.  Transthoracic Doppler echocardiography - noninvasive diagnostic window for coronary flow reserve assessment.

Authors:  Paweł Petkow Dimitrow
Journal:  Cardiovasc Ultrasound       Date:  2003-04-11       Impact factor: 2.062
View more
  1 in total

1.  Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker.

Authors:  Christine Pacheco; Janet Wei; Chrisandra Shufelt; Tara C Hitzeman; Galen Cook-Wiens; Carl J Pepine; Eileen Handberg; R David Anderson; John Petersen; TingTing Hong; Robin M Shaw; C Noel Bairey Merz
Journal:  Clin Cardiol       Date:  2021-09-16       Impact factor: 3.287
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.